Aquaculture for all

Weekly Overview: Mystery Shrimp Disease Hits Mexico

Crustaceans Health Economics +1 more

ANALYSIS Young shrimp in two Mexican states have been hit by as an-yet unidentified disease, while Nicaragua has banned imports of Asian shrimp for fear of allowing in EMS. Fish farming has overtaken the beef industry in protein production for the second year running. New labelling rules in the EU fish industry will help inform consumers. Marine Harvest has failed to acquire Cermaq.

Nicaragua has banned imports of shrimp from Asia due to concerns over the spread of Early Mortality Syndrome (EMS).

A mystery shrimp disease in Mexico has also sparked fears of a EMS outbreak. Young shrimp on farms in the states of Sinaloa and Sonora are currently being affected, reported local newspaper Noroeste.

For two years running, the global fish farming industry has produced more animal protein than the cattle industry in what scientists are calling a landmark stage in the progression of consumer diets.

In 2012, world aquaculture produced 66 million tons of fish, outstripping the beef industry by three million tons. This is the consequence of grain market trends, health education and a growing need to source food more sustainably, according to a report from the Earth Policy Institute.

A new system for labelling fish products has been agreed by the European Union, giving consumers information about the way their fish is caught and sets a precedent for clearer labelling of other animal products.

Marine Harvest has failed to gather enough votes to acquire Cermaq. The company needed 33.4 per cent to complete the acquisition.

The Ministry of Trade and Industry in Norway has implemented a process for the possible purchase of shares in Cermaq ASA. All shareholders of Cermaq ASA have been invited to submit any offer for sale at Handelsbanken Capital Markets, which the Ministry has engaged as a mediator in for this process.

After the failed acquisition, Marine Harvest sold more than 3.3 million shares in Cermaq at an average price of NOK105.33 per share. The company has retained 1.7 million Cermaq shares, which represent less than two per cent of the outstanding shares.

Create an account now to keep reading

It'll only take a second and we'll take you right back to what you were reading. The best part? It's free.

Already have an account? Sign in here